| Literature DB >> 27022358 |
Seema Bibi1, Sanober Ashfaque2, Naeem Ahmed Laghari3.
Abstract
OBJECTIVES: In Pakistan gynaecological cancers are among the leading causes of women's morbidity and mortality posing huge financial burden on families, communities and state. Due to lack of national cancer registry exact facts and figures are unknown therefore this study was planned to find out prevalence, age, site and stage of presentation of gynaecological cancers at Nuclear Institute of Medicine and Radiotherapy (NIMRA), Jamshoro.Entities:
Keywords: Advance stage; Gynaecological cancer
Year: 2016 PMID: 27022358 PMCID: PMC4795850 DOI: 10.12669/pjms.321.8663
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Site distribution of gynaecological tumors N = 231.
| S. # | Site of tumor | Number | Percentage |
|---|---|---|---|
| 1 | Ovary | 70 | 30% |
| 2 | Cervix | 64 | 28% |
| 3 | Gestational Trophoblastic Tumors | 62 | 27% |
| 4 | Endometrium | 22 | 10% |
| 5 | Vagina | 08 | 3% |
| 6 | Vulva | 05 | 2% |
Age distribution of female genitaltract tumors N = 231.
| Age (Year) | Ovarian Cancers | Cervical Cancers | GTN | Endometrial Cancers | Vaginal Cancers | Vulval Cancers | Total No. + % |
|---|---|---|---|---|---|---|---|
| < 20 | 5(2%) | 0 | 5(2%) | 0 | 1(0.4%) | 0 | 11(5%) |
| 20–29 | 8(3%) | 3(1%) | 26(11%) | 0 | 0 | 0 | 37(16%) |
| 30–39 | 6(3%) | 9(4%) | 20(9%) | 0 | 0 | 0 | 35(15%) |
| 40–49 | 16(7%) | 13(6%) | 10(4%) | 1(0.4%) | 3(1%) | 0 | 43(19%) |
| 50–59 | 14(6%) | 17(7%) | 1(0.4%) | 10(4%) | 2(1%) | 3(1%) | 47(20%) |
| > 60 | 21(9%) | 22(10%) | 0 | 11(5%) | 2(1%) | 2(1%) | 58(25%) |
Stage of cancers at the time of presentation N = 175*.
| Site | Stage I | Stage II | Stage III | Stage IV | Total |
|---|---|---|---|---|---|
| Early Stage | Advance Stage | ||||
| Ovarian Cancer | 2(3%) | 19(27%) | 23(33%) | 26(37%) | 70(40%) |
| Cervical Cancer | 6(9%) | 21(33%) | 29(45%) | 8(13%) | 64(36.5%) |
| Endometrial Cancer | 2(9%) | 5(23%) | 11(50%) | 4(19%) | 22(12.5%) |
| Vaginal Cancer | 1(12%) | 2(25%) | 3(38%) | 2(25%) | 8(4.5%) |
| Vulval Cancer | 1(20%) | 1(20%) | 1(20%) | 2(40%) | 5(3%) |
| Chorio Carcinoma | 0 | 0 | 1(17%) | 5(83%) | 6(3.4%) |
56 Cases of benign trophoblastic tumors were excluded from this table.